Dilshat Djumanov MPhil, PhD Director of Data Science
Dilshat has an in depth knowledge of data management and data analysis for adaptive clinical trials and QTc studies. Dilshat has a background in IT and demonstrable knowledge of process automation and improvement.
Having worked at Richmond Pharmacology for 14 years, he has led pioneering software development projects which have ensured Richmond Pharmacology’s data management and other processes are efficient, transparent and fast.
Dilshat’s experience is backed by his academic achievements, including a MSc in Computer Sciences, a MPhil in Medical Engineering and a PhD in Computational Fluid Dynamics.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.